Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 4/20 | 0.45 |
| ▸ | CDK9 | P50750 | 4/20 | 0.45 |
| ▸ | CDK2 | P24941 | 2/20 | 0.45 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 1/20 | 0.40 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.40 |
| ▸ | RASGRP3 | Q8IV61 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6955491 | 0.95 | CCNT1 (0.42) | CCNT1CDK9CDK2CCNA2MAPT | |
| SCHEMBL6956384 | 0.92 | CCNT1 (0.46) | CCNT1CDK9CDK2CCNA2 | |
| SCHEMBL7164524 | 0.89 | CCNT1 (0.47) | CCNT1CDK9CDK2CCNA2 | |
| SCHEMBL7500940 | 0.86 | CCNT1 (0.46) | CCNT1CDK9CDK2CCNA2 | |
| SCHEMBL6947835 | 0.84 | CCNT1 (0.44) | CCNT1CDK9CDK2CCNA2MAPT | |
| SCHEMBL7508601 | 0.83 | CCNT1 (0.47) | CCNT1CDK9CDK2CCNA2 | |
| SCHEMBL6956508 | 0.83 | CCNT1 (0.42) | CCNT1CDK9CDK2CCNA2ALDH1A1 | |
| SCHEMBL6954175 | 0.82 | CCNT1 (0.43) | CCNT1CDK9CDK2CCNA2RASGRP3 | |
| SCHEMBL6954265 | 0.82 | CDK9 (0.39) | CCNT1CDK9CDK2CCNA2PRKCA | |
| Hydrochloric Acid SCHEMBL6954170 | 0.81 | CCNT1 (0.42) | CCNT1CDK9CDK2CCNA2RASGRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1155595-C | Substituted pyrroles as antiproliferative agents for the treatment of cancer | - | 2004-06-30 | — | — | CN | claimed |
| EP-1224181-B1 | SUBSTITUTED PYRROLES AS ANTIPROLIFERATIVE AGENTS FOR THE TREATMENT OF CANCER | HOFFMANN LA ROCHE (CH) | 2003-12-03 | — | — | EP | claimed |
| CN-1378545-A | Substituted pyrroles as antiproliferative agents for treatment of cancer | HOFFMANN LA ROCHE (CH) | 2002-11-06 | — | — | CN | claimed |
| CN-1155595-C | Substituted pyrroles as antiproliferative agents for the treatment of cancer | - | 2004-06-30 | — | — | CN | disclosed |
| CN-1378545-A | Substituted pyrroles as antiproliferative agents for treatment of cancer | HOFFMANN LA ROCHE (CH) | 2002-11-06 | — | — | CN | disclosed |